Microscale radiosynthesis, preclinical imaging and dosimetry study of [18F]AMBF3-TATE: A potential PET tracer for clinical imaging of somatostatin receptors

Lisova, Ksenia; Sergeev, Maxim; Evans-Axelsson, Susan; Stuparu, Andreea D.; Beykan, Seval; Collins, Jeffrey; Jones, Jason; Lassmann, Michael; Herrmann, Ken; Perrin, David; Lee, Jason T.; Slavik, Roger; van Dam, R. Michael

doi:10.1016/j.nucmedbio.2018.04.001

Title: Microscale radiosynthesis, preclinical imaging and dosimetry study of [18F]AMBF3-TATE: A potential PET tracer for clinical imaging of somatostatin receptors

Full Record
Other Related Research

Authors:: Lisova, Ksenia; Sergeev, Maxim; Evans-Axelsson, Susan; Stuparu, Andreea D.; Beykan, Seval; Collins, Jeffrey; Jones, Jason; Lassmann, Michael; Herrmann, Ken; Perrin, David; Lee, Jason T.; Slavik, Roger; van Dam, R. Michael

Publication Date:: Fri Jun 01 00:00:00 EDT 2018

Sponsoring Org.:: USDOE

OSTI Identifier:: 1582751

Grant/Contract Number:: SC0012353

Resource Type:: Publisher's Accepted Manuscript

Journal Name:: Nuclear Medicine and Biology

Additional Journal Information:: Journal Name: Nuclear Medicine and Biology Journal Volume: 61 Journal Issue: C; Journal ID: ISSN 0969-8051

Publisher:: Elsevier

Country of Publication:: United Kingdom

Language:: English

Citation Formats


                    Lisova, Ksenia, Sergeev, Maxim, Evans-Axelsson, Susan, Stuparu, Andreea D., Beykan, Seval, Collins, Jeffrey, Jones, Jason, Lassmann, Michael, Herrmann, Ken, Perrin, David, Lee, Jason T., Slavik, Roger, and van Dam, R. Michael. Microscale radiosynthesis, preclinical imaging and dosimetry study of [18F]AMBF3-TATE: A potential PET tracer for clinical imaging of somatostatin receptors.  United Kingdom: N. p., 2018. 
Web.  doi:10.1016/j.nucmedbio.2018.04.001.

Copy to clipboard


                    Lisova, Ksenia, Sergeev, Maxim, Evans-Axelsson, Susan, Stuparu, Andreea D., Beykan, Seval, Collins, Jeffrey, Jones, Jason, Lassmann, Michael, Herrmann, Ken, Perrin, David, Lee, Jason T., Slavik, Roger, & van Dam, R. Michael. Microscale radiosynthesis, preclinical imaging and dosimetry study of [18F]AMBF3-TATE: A potential PET tracer for clinical imaging of somatostatin receptors.  United Kingdom.  https://doi.org/10.1016/j.nucmedbio.2018.04.001

Copy to clipboard


                    Lisova, Ksenia, Sergeev, Maxim, Evans-Axelsson, Susan, Stuparu, Andreea D., Beykan, Seval, Collins, Jeffrey, Jones, Jason, Lassmann, Michael, Herrmann, Ken, Perrin, David, Lee, Jason T., Slavik, Roger, and van Dam, R. Michael. Fri .  
"Microscale radiosynthesis, preclinical imaging and dosimetry study of [18F]AMBF3-TATE: A potential PET tracer for clinical imaging of somatostatin receptors".  United Kingdom.  https://doi.org/10.1016/j.nucmedbio.2018.04.001.

Copy to clipboard


                    
@article{osti_1582751,

  title        = {Microscale radiosynthesis, preclinical imaging and dosimetry study of [18F]AMBF3-TATE: A potential PET tracer for clinical imaging of somatostatin receptors},

  author       = {Lisova, Ksenia and Sergeev, Maxim and Evans-Axelsson, Susan and Stuparu, Andreea D. and Beykan, Seval and Collins, Jeffrey and Jones, Jason and Lassmann, Michael and Herrmann, Ken and Perrin, David and Lee, Jason T. and Slavik, Roger and van Dam, R. Michael},

  abstractNote = {},

  doi          = {10.1016/j.nucmedbio.2018.04.001},

  journal      = {Nuclear Medicine and Biology},

  number       = C,

  volume       = 61,

  place        = {United Kingdom},

  year         = {Fri Jun 01 00:00:00 EDT 2018},

  month        = {Fri Jun 01 00:00:00 EDT 2018}

}

Copy to clipboard

Journal Article:

Free Publicly Available Full Text

Accepted Manuscript (Publisher)

Publisher's Version of Record
https://doi.org/10.1016/j.nucmedbio.2018.04.001

Other availability

Search WorldCat to find libraries that may hold this journal

Citation Metrics:

Cited by: 22 works

Citation information provided by
Web of Science

Save / Share:

Export Metadata

Save to My Library

Similar Records in DOE PAGES and OSTI.GOV collections:

Microscale radiosynthesis, preclinical imaging and dosimetry study of [ 18 F]AMBF 3 -TATE: A potential PET tracer for clinical imaging of somatostatin receptors

Journal Article Lisova, Ksenia ; Sergeev, Maxim ; Evans-Axelsson, Susan ; ... - Nuclear Medicine and Biology

Not provided.
https://doi.org/10.1016/j.nucmedbio.2018.04.001
Positron emission tomography study on pancreatic somatostatin receptors in normal and diabetic rats with {sup 68}Ga-DOTA-octreotide: A potential PET tracer for beta cell mass measurement

Journal Article Sako, Takeo ; Division of Molecular Imaging, Institute of Biomedical Research and Innovation, 2-2 Minatojima-minamimachi, Chuo-ku, Kobe, Hyogo 650-0047 ; Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo 650-0017 ; ... - Biochemical and Biophysical Research Communications

Highlights: •PET images showed high uptake of {sup 68}Ga-DOTA-octreotide in the normal pancreas. •{sup 68}Ga-DOTA-octreotide specifically binds to somatostatin receptors in the pancreas. •The pancreatic uptake of {sup 68}Ga-DOTA-octreotide was decreased in the diabetic rats. •{sup 68}Ga-DOTA-octreotide could be a candidate PET probe to measure the beta cell mass. -- Abstract: Diabetes mellitus (DM) is a metabolic disorder characterized by hyperglycemia, and the loss or dysfunction of pancreatic beta cells has been reported before the appearance of clinical symptoms and hyperglycemia. To evaluate beta cell mass (BCM) for improving the detection and treatment of DM at earlier stages, we focusedmore »« less
https://doi.org/10.1016/J.BBRC.2013.11.001
Gallium-67/Gallium-68-[DFO]-octreotide-a potential radiopharmaceutical for PET imaging of somatostatin receptor-positive tumors: Synthesis and radiolabeling in vitro and preliminary in vivo studies

Journal Article Smith-Jones, P M ; Stolz, B ; Bruns, C - Journal of Nuclear Medicine Technology

When labeled with gamma-emitting radionuclides, somatostatin analogs have the potential to localize somatostatin receptor-positive tumors using gamma camera scintigraphy. The authors present a somatostatin analog, [DFO]-octreotide (SDZ 216-927), that comprises desferrioxamine B coupled to octreotide via a succinyl linker. This conjugate can be labeled with either {sup 67}Ga-labeled conjugate is stable in vitro to autoradiolysis over a 24-hr period. Rats bearing a somatostatin receptor-positive pancreatic islet cell tumor were injected with 20 MBq of {sup 67}Ga[DFO] octreotide (33 GBq {sup 67}Ga/{mu}mole). After 1 hr, the accumulation of {sup 67}Ga[DFO]-octreotide was 0.38 {plus_minus} 0.08 %ID/g and the tumor-to-nontumor ratios for blood,more »« less
The Impact of Somatostatin Receptor–Directed PET/CT on the Management of Patients with Neuroendocrine Tumor: A Systematic Review and Meta-Analysis

Journal Article Barrio, Martin ; Czernin, Johannes ; Fanti, Stefano ; ... - Journal of Nuclear Medicine

Not provided.
https://doi.org/10.2967/jnumed.116.185587
18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial

Journal Article Calais, Jeremie ; Ceci, Francesco ; Eiber, Matthias ; ... - Lancet Oncology

Not provided.
https://doi.org/10.1016/s1470-2045(19)30415-2

Similar Records